What's breaking now, across thousands of outlets.
Scientific Reports, Published online: 27 August 2026; doi:10.1038/s41598-026-67546-2 Early erythrocytosis and predictors of hematocrit response after SGLT2 inhibitor initiation in type 2 diabetes
We haven't written up this one. Scientific Reports has the full story — the link below goes straight to it.
The FDA has approved a drug that could extend the life of patients with late-stage pancreatic cancer. CBS News' medical correspondent Dr. Céline Gounder has more.
International body declares Uganda Ebola-free after 42 days without new transmission, though cases rise in DR Congo.
GREEN BAY, Wis. (WFRV) – As high school athletes across Wisconsin return to competition this fall, research involving thousands of student-athletes is highlighting the role access to athletic trainers…
FDA officials gave expedited approval to daraxonrasib, which blocks a mutated protein that fuels tumor growth
Since early July, healthcare workers fighting the epidemic have staged sporadic strikes to demand their salaries. The government has acknowledged the embezzlement of funds, which has undermined the…
After a sudden collapse, one veteran educator learnt why small warning signs and regular health checks should not be ignored.
